GlucoTrack logo
GlucoTrack
GCTK | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.31 (-38.75%)
At close: Nov 2, 2026, 3:47 PM ET

GlucoTrack Company Profile

Company profile explained

Company Profile

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Key Executives

Name Position
Erik C. Emerson CEO & Director
Avner Gal MSc.EE Co-Founder, Chairman Emeritus & Consultant
David Malka Co-Founder
Drinda Benjamin Chief Commercial Officer
Mark Tapsak Chief Scientific Officer
Paul V. Goode Chief Technical Officer & President
Vincent Wong Chief Operations Officer

Latest SEC Filings

Date Type Title
Oct 29, 2026 8-K Current Report
Oct 28, 2026 8-K Current Report
Oct 22, 2026 8-K Current Report
Oct 19, 2026 8-K Current Report
Oct 13, 2026 PRE 14A Filing
Oct 14, 2026 S-1/A [Amend] Filing
Oct 13, 2026 425 Filing
Oct 13, 2026 8-K/A [Amend] Current Report
Sep 28, 2026 8-K Current Report
Sep 24, 2026 424B5 Filing
View All SEC Filings ➞
GlucoTrack
GlucoTrack logo
Country United States
IPO Date Apr 25, 2013
Industry Medical - Devices
Sector Healthcare
Employees 15
CEO Erik Emerson

Contact Details

301 Route 17 North Rutherford, New Jersey 07070 United States

Stock Details

Ticker Symbol GCTK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001506983
CUSIP Number 45824Q879
ISIN Number US45824Q8794
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.